|
|
Line 1: |
Line 1: |
| ==List of indications==
| | #REDIRECT [[Clopidogrel#Administration and Monitoring]] |
| <br>
| |
| <font size="4">[[Clopidogrel instructions for administration#Recent MI, Recent Stroke, or Established Peripheral Arterial Disease|Recent MI, Recent Stroke, or Established Peripheral Arterial Disease]]</font>
| |
| <br>
| |
| <br>
| |
| <font size="4">[[Clopidogrel instructions for administration#Acute Coronary Syndrome|Acute Coronary Syndrome]]</font>
| |
| <br>
| |
| <br>
| |
| ----
| |
| <br>
| |
| <br>
| |
| <br>
| |
| <br>
| |
| <br>
| |
| <br>
| |
| ==Recent MI, Recent Stroke, or Established Peripheral Arterial Disease==
| |
| | |
| The recommended daily dose of Plavix is 75 mg once daily.
| |
| | |
| ''[[Clopidogrel instructions for administration#List of indications|Return to top]]''
| |
| <br>
| |
| | |
| ==Acute Coronary Syndrome==
| |
| | |
| For patients with [[acute coronary syndrome]] ([[unstable angina]] / non-Q-wave MI), Plavix should be initiated with a single 300-mg loading dose and then continued at 75 mg once daily. [[Aspirin]] (75 mg-325 mg once daily) should be initiated and continued in combination with Plavix. In CURE, most patients with [[Acute Coronary Syndrome]] also received [[heparin]] acutely.
| |
| | |
| '''Plavix can be administered with or without food.'''
| |
| | |
| No dosage adjustment is necessary for elderly patients or patients with renal disease.
| |
| | |
| ''[[Clopidogrel instructions for administration#List of indications|Return to top]]''
| |
| <br>
| |
| | |
| | |
| {{FDA}}
| |
| | |
| | |
| | |
| | |
| [[Category:Drugs]]
| |